Efficacy of Low Impact Aerobic Training Versus Upper Limb Strengthening Exercise in Fatigue Level among Individuals with Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.37506/q9qf8640Keywords:
Chronic Obstructive Pulmonary Disease, Aerobic training, Upper extremity exercise, BORG Scale, Fatigue Severity ScaleAbstract
Background: A disorder characterized by airway obstruction and breathing difficulty is known as chronic
obstructive pulmonary disease. Fatigue is one of the typical signs and symptoms of COPD. Fatigue is the term
used to describe a persistent feeling of exhaustion, and it can have a significant negative influence on person’s
capacity to carry out everyday tasks.
Purpose: The purpose of this study is to analyze how low impact aerobic training and upper limb strengthening
exercise is effective in dyspnea and fatigue level among individuals with COPD.
Materials and Methods: The 106 subjects were selected based on inclusion and exclusion criteria from Hepziba
Chest Clinic and Spirometry centre, Nagercoil. The pre and post-test values were measured using the BORG scale
and Fatigue Severity Scale. The subjects were allocated into two groups. Low impact Aerobic training group:(n=53)
received aerobic training with conventional exercise and Upper limb strengthening group:(n=53) received upper
limb strengthening exercise with conventional exercise. The study was done for four weeks. The entire procedure
was performed from October 2022 to july 2023
Results: When comparing the low impact Aerobic training group with upper limb strengthening group, the low
impact Aerobic training group indicates significant (p<0.0001) effect in lowering the fatigue level as assessed by
Borg scale and Fatigue Severity Scale.
Conclusion: The study concluded that Low impact Aerobic training had a significant effect compared to upper
limb strengthening exercise on Dyspnea and Fatigue Severity Scale among individuals with COPD.
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.